Trulieve Cannabis Corp. is expanding its presence in Florida with the opening of a new medical cannabis dispensary in Lake Worth. The grand opening celebration will take place on Friday, September 27th, featuring music, special offers, and opportunities to learn about cannabis legalization in the state.
Tilray Medical, a division of Tilray Brands, has expanded its presence in Australia with the launch of Redecan EU-GMP certified medical cannabis products, offering patients in Australia a wider selection of premium quality medical cannabis options.
Martin Condon, a prominent cannabis advocate in Ireland, has been convicted of cultivating cannabis after openly planting hemp plants in Cork City. Condon, who suffers from epilepsy, argued that his actions were a form of civil disobedience to challenge restrictive cannabis laws and initiate a national conversation about medical access. Despite the non-intoxicating nature of the hemp plants, Condon was found guilty on five out of six counts, with sentencing deferred until November.
A new survey conducted in Germany by Bloomwell Group GmbH reveals that 94% of respondents use cannabis for at least one health reason, highlighting the potential of the country’s medical cannabis market. Despite recent legalization, access to medical cannabis remains limited, with many consumers resorting to the illicit market due to limited physician knowledge and stigma. The survey calls for greater public awareness, education for physicians, and improved access to telemedicine services to ensure safe and reliable access to medical cannabis.
IM Cannabis Corp., a leading medical cannabis company operating in Israel and Germany, has appointed Shmulik Arbel to its board of directors. Arbel brings extensive experience in strategic planning, finance, and corporate governance, further solidifying the company’s commitment to growth and sustainable profitability.
Rwanda is positioning itself as a major player in the global medical cannabis market. The country legalized medical cannabis in 2021, and investments are pouring in to establish production facilities. With its fertile land and favorable climate, Rwanda aims to become a significant contributor to the growing medical marijuana industry, attracting foreign investment and generating substantial economic benefits.
Aurora Cannabis and Vectura Fertin Pharma have partnered to launch a new CBD lozenge in Canada. This marks Vectura Fertin Pharma’s first medical cannabis CBD lozenge in the Canadian market and represents a significant step forward in their collaboration with Aurora. The lozenge, manufactured by Cogent International, a subsidiary of Vectura Fertin Pharma, offers a novel dissolvable format for easy dosing.
The Mississippi State Legislature has passed legislation establishing the Mississippi Medical Cannabis Research Program at the University of Mississippi, aiming to deepen understanding of medical marijuana’s therapeutic potential. This bipartisan effort leverages Ole Miss’s longstanding expertise in cannabis research and provides funding for scientific investigations and educational initiatives.
MTL Cannabis Corp. announced impressive first-quarter 2025 financial results, highlighting significant revenue growth, improved profitability, and positive cash flow. The company’s focus on craft quality cannabis products and expansion into the medical cannabis market are driving its success.
Argentina’s Ministry of Health has implemented stricter rules for its medical cannabis program, REPROCANN, aiming to improve oversight and ensure professional competency. These changes affect solidarity cultivators, NGOs, and physicians, potentially impacting patient access to cannabis treatments.
